US Patent Issued to Novartis on Jan. 28 for "Protein kinase C inhibitors for treatment of uveal melanoma" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,097, issued on Jan. 28, was assigned to Novartis AG (Basel, Switzerland).

"Protein kinase C inhibitors for treatment of uveal melanoma" was invented by Vesselina Cooke (Cambridge, Mass.), Michael Scott Visser (Cambridge, Mass.), Andrew Wylie (Newton, Mass.), Padmaja Yerramilli-Rao (Cambridge, Mass.) and Xu Zhu (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to use of a protein kinase C (PKC) inhibitor in the treatment or prevention of proliferative diseases. The disclosure also relates to corresponding pharmaceutical formulations, uses, methods, combinations, and related disclosure embodiments. The dis...